-
1
-
-
0031573132
-
Derivation of HLA-A11/Kb transgenic mice: Functional CTL repertoire and recognition of human A11-restricted CTL epitopes
-
Alexander, J., C. Oseroff, J. Sidney, P. Wentworth, E. Keogh, G. Hermanson, F. V. Chisari, R. T. Kubo, H. M. Grey, and A. Sette. 1997. Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes. J. Immunol. 159:4753-4761.
-
(1997)
J. Immunol
, vol.159
, pp. 4753-4761
-
-
Alexander, J.1
Oseroff, C.2
Sidney, J.3
Wentworth, P.4
Keogh, E.5
Hermanson, G.6
Chisari, F.V.7
Kubo, R.T.8
Grey, H.M.9
Sette, A.10
-
2
-
-
0037313995
-
Derivation of HLA-B*0702 transgenic mice: Functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes
-
Alexander, J., C. Oseroff, J. Sidney, and A. Sette. 2003. Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes. Hum. Immunol. 64:211-223.
-
(2003)
Hum. Immunol
, vol.64
, pp. 211-223
-
-
Alexander, J.1
Oseroff, C.2
Sidney, J.3
Sette, A.4
-
3
-
-
0027468757
-
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein
-
Bertoletti, A., F. V. Chisari, A. Penna, S. Guilhot, L. Galati, G. Missale, P. Fowler, H. J. Schlicht, A. Vitiello, R. C. Chesnut, F. Fiaccadori, and C. Ferrari. 1993. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J. Virol. 67:2376-2380.
-
(1993)
J. Virol
, vol.67
, pp. 2376-2380
-
-
Bertoletti, A.1
Chisari, F.V.2
Penna, A.3
Guilhot, S.4
Galati, L.5
Missale, G.6
Fowler, P.7
Schlicht, H.J.8
Vitiello, A.9
Chesnut, R.C.10
Fiaccadori, F.11
Ferrari, C.12
-
4
-
-
0345306198
-
Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control
-
Bertoletti, A., M. Maini, and R. Williams. 2003. Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control. Antiviral Res. 60:61-66.
-
(2003)
Antiviral Res
, vol.60
, pp. 61-66
-
-
Bertoletti, A.1
Maini, M.2
Williams, R.3
-
5
-
-
0030811688
-
Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis
-
Bertoni, R., J. Sidney, P. Fowler, R. W. Chesnut, F. V. Chisari, and A. Sette. 1997. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Investig. 100:503-513.
-
(1997)
J. Clin. Investig
, vol.100
, pp. 503-513
-
-
Bertoni, R.1
Sidney, J.2
Fowler, P.3
Chesnut, R.W.4
Chisari, F.V.5
Sette, A.6
-
6
-
-
0141532308
-
Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease
-
Bienzle, U., M. Gunther, R. Neuhaus, P. Vandepapeliere, J. Vollmar, A. Lun, and P. Neuhaus. 2003. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 38:811-819.
-
(2003)
Hepatology
, vol.38
, pp. 811-819
-
-
Bienzle, U.1
Gunther, M.2
Neuhaus, R.3
Vandepapeliere, P.4
Vollmar, J.5
Lun, A.6
Neuhaus, P.7
-
7
-
-
0032169470
-
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
-
Boni, C., A. Bertoletti, A. Penna, A. Cavalli, M. Pilli, S. Urbani, P. Scognamiglio, R. Boehme, R. Panebianco, F. Fiaccadori, and C. Ferrari. 1998. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J. Clin. Investig. 102:968-975.
-
(1998)
J. Clin. Investig
, vol.102
, pp. 968-975
-
-
Boni, C.1
Bertoletti, A.2
Penna, A.3
Cavalli, A.4
Pilli, M.5
Urbani, S.6
Scognamiglio, P.7
Boehme, R.8
Panebianco, R.9
Fiaccadori, F.10
Ferrari, C.11
-
8
-
-
17744383748
-
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy
-
Boni, C., A. Penna, G. S. Ogg, A. Bertoletti, M. Pilli, C. Cavallo, A. Cavalli, S. Urbani, R. Boehme, R. Panebianco, F. Fiaccadori, and C. Ferrari. 2001. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 33:963-971.
-
(2001)
Hepatology
, vol.33
, pp. 963-971
-
-
Boni, C.1
Penna, A.2
Ogg, G.S.3
Bertoletti, A.4
Pilli, M.5
Cavallo, C.6
Cavalli, A.7
Urbani, S.8
Boehme, R.9
Panebianco, R.10
Fiaccadori, F.11
Ferrari, C.12
-
9
-
-
0033795497
-
Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice
-
Braun, S., C. Thioudellet, P. Rodriguez, D. Ali-Hadji, F. Perraud, N. Accart, J. M. Balloul, C. Halluard, B. Acres, B. Cavallini, and A. Pavirani. 2000. Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice. Gene Ther. 7:1447-1457.
-
(2000)
Gene Ther
, vol.7
, pp. 1447-1457
-
-
Braun, S.1
Thioudellet, C.2
Rodriguez, P.3
Ali-Hadji, D.4
Perraud, F.5
Accart, N.6
Balloul, J.M.7
Halluard, C.8
Acres, B.9
Cavallini, B.10
Pavirani, A.11
-
10
-
-
33746166392
-
Predicting population coverage of T-cell epitope-based diagnostics and vaccines
-
Bui, H. H., J. Sidney, K. Dinh, S. Southwood, M. J. Newman, and A. Sette. 2006. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 7:153-157.
-
(2006)
BMC Bioinformatics
, vol.7
, pp. 153-157
-
-
Bui, H.H.1
Sidney, J.2
Dinh, K.3
Southwood, S.4
Newman, M.J.5
Sette, A.6
-
11
-
-
33745660321
-
Antiviral treatment for chronic hepatitis B virus infection-immune modulation or viral suppression?
-
Buster, E. H., and H. L. Janssen. 2006. Antiviral treatment for chronic hepatitis B virus infection-immune modulation or viral suppression? Neth. J. Med. 64:175-185.
-
(2006)
Neth. J. Med
, vol.64
, pp. 175-185
-
-
Buster, E.H.1
Janssen, H.L.2
-
12
-
-
13944265920
-
Immune tolerance split between hepatitis B virus precore and core proteins
-
Chen, M., M. Sallberg, J. Hughes, J. Jones, L. G. Guidotti, F. V. Chisari, J. N. Billaud, and D. R. Milich. 2005. Immune tolerance split between hepatitis B virus precore and core proteins. J. Virol. 79:3016-3027.
-
(2005)
J. Virol
, vol.79
, pp. 3016-3027
-
-
Chen, M.1
Sallberg, M.2
Hughes, J.3
Jones, J.4
Guidotti, L.G.5
Chisari, F.V.6
Billaud, J.N.7
Milich, D.R.8
-
13
-
-
0029087093
-
-
Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathology. Springer Semin. Immunopathol. 17:261-281.
-
Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathology. Springer Semin. Immunopathol. 17:261-281.
-
-
-
-
14
-
-
0025739789
-
Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen
-
Ferrari, C., A. Bertoletti, A. Penna, A. Cavalli, A. Valli, G. Missale, M. Pilli, P. Fowler, T. Giuberti, F. V. Chisari, and F. Fiaccadori. 1991. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J. Clin. Investig. 88:214-222.
-
(1991)
J. Clin. Investig
, vol.88
, pp. 214-222
-
-
Ferrari, C.1
Bertoletti, A.2
Penna, A.3
Cavalli, A.4
Valli, A.5
Missale, G.6
Pilli, M.7
Fowler, P.8
Giuberti, T.9
Chisari, F.V.10
Fiaccadori, F.11
-
15
-
-
0030021968
-
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
-
Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
-
(1996)
Immunity
, vol.4
, pp. 25-36
-
-
Guidotti, L.G.1
Ishikawa, T.2
Hobbs, M.V.3
Matzke, B.4
Schreiber, R.5
Chisari, F.V.6
-
16
-
-
0033617583
-
Viral clearance without destruction of infected cells during acute HBV infection
-
Guidotti, L. G., R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
-
(1999)
Science
, vol.284
, pp. 825-829
-
-
Guidotti, L.G.1
Rochford, R.2
Chung, J.3
Shapiro, M.4
Purcell, R.5
Chisari, F.V.6
-
17
-
-
0035961542
-
Overview of the pathogenesis, prophylaxis and therapeutics of viral hepatitis B, with focus on reduction to practical applications
-
Hilleman, M. R. 2001. Overview of the pathogenesis, prophylaxis and therapeutics of viral hepatitis B, with focus on reduction to practical applications. Vaccine 19:1837-1848.
-
(2001)
Vaccine
, vol.19
, pp. 1837-1848
-
-
Hilleman, M.R.1
-
18
-
-
0033120573
-
Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes
-
Ishioka, G. Y., J. Fikes, G. Hermanson, B. Livingston, C. Crimi, M. Qin, M. F. del Guercio, C. Oseroff, C. Dahlberg, J. Alexander, R. W. Chesnut, and A. Sette. 1999. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J. Immunol. 162:3915-3925.
-
(1999)
J. Immunol
, vol.162
, pp. 3915-3925
-
-
Ishioka, G.Y.1
Fikes, J.2
Hermanson, G.3
Livingston, B.4
Crimi, C.5
Qin, M.6
del Guercio, M.F.7
Oseroff, C.8
Dahlberg, C.9
Alexander, J.10
Chesnut, R.W.11
Sette, A.12
-
19
-
-
19944428132
-
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial
-
Janssen, H. L., M. van Zonneveld, H. Senturk, S. Zeuzem, U. S. Akarca, Y. Cakaloglu, C. Simon, T. M. So, G. Gerken, R. A. de Man, H. G. Niesters, P. Zondervan, B. Hansen, S. W. Schalm, et al. 2005. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365:123-129.
-
(2005)
Lancet
, vol.365
, pp. 123-129
-
-
Janssen, H.L.1
van Zonneveld, M.2
Senturk, H.3
Zeuzem, S.4
Akarca, U.S.5
Cakaloglu, Y.6
Simon, C.7
So, T.M.8
Gerken, G.9
de Man, R.A.10
Niesters, H.G.11
Zondervan, P.12
Hansen, B.13
Schalm, S.W.14
-
20
-
-
0037019913
-
Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: Induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers
-
Jung, M. C., N. Gruner, R. Zachoval, W. Schraut, T. Gerlach, H. Diepolder, C. A. Schirren, M. Page, J. Bailey, E. Birtles, E. Whitehead, J. Trojan, S. Zeuzem, and G. R. Pape. 2002. Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers. Vaccine 20:3598-3612.
-
(2002)
Vaccine
, vol.20
, pp. 3598-3612
-
-
Jung, M.C.1
Gruner, N.2
Zachoval, R.3
Schraut, W.4
Gerlach, T.5
Diepolder, H.6
Schirren, C.A.7
Page, M.8
Bailey, J.9
Birtles, E.10
Whitehead, E.11
Trojan, J.12
Zeuzem, S.13
Pape, G.R.14
-
21
-
-
0036337681
-
Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: Implications for immunotherapy of persistent viral infections
-
Kakimi, K., M. Isogawa, J. Chung, A. Sette, and F. V. Chisari. 2002. Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J. Virol. 76:8609-8620.
-
(2002)
J. Virol
, vol.76
, pp. 8609-8620
-
-
Kakimi, K.1
Isogawa, M.2
Chung, J.3
Sette, A.4
Chisari, F.V.5
-
22
-
-
4644308995
-
Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity
-
Kondo, Y., S. Asabe, K. Kobayashi, M. Shiina, H. Niitsuma, Y. Ueno, T. Kobayashi, and T. Shimosegawa. 2004. Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity. J. Med. Virol. 74:425-433.
-
(2004)
J. Med. Virol
, vol.74
, pp. 425-433
-
-
Kondo, Y.1
Asabe, S.2
Kobayashi, K.3
Shiina, M.4
Niitsuma, H.5
Ueno, Y.6
Kobayashi, T.7
Shimosegawa, T.8
-
23
-
-
1642410856
-
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
-
Lavanchy, D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 11:97-107.
-
(2004)
J. Viral Hepat
, vol.11
, pp. 97-107
-
-
Lavanchy, D.1
-
24
-
-
0031204408
-
The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection
-
Livingston, B. D., C. Crimi, H. Grey, G. Ishioka, F. V. Chisari, J. Fikes, H. Grey, R. W. Chesnut, and A. Sette. 1997. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection. J. Immunol. 159:1383-1392.
-
(1997)
J. Immunol
, vol.159
, pp. 1383-1392
-
-
Livingston, B.D.1
Crimi, C.2
Grey, H.3
Ishioka, G.4
Chisari, F.V.5
Fikes, J.6
Grey, H.7
Chesnut, R.W.8
Sette, A.9
-
25
-
-
0033104746
-
Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans
-
Livingston, B. D., J. Alexander, C. Crimi, C. Oseroff, E. Celis, K. Daly, L. G. Guidotti, F. V. Chisari, J. Fikes, R. W. Chesnut, and A. Sette. 1999. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. J. Immunol. 162:3088-3095.
-
(1999)
J. Immunol
, vol.162
, pp. 3088-3095
-
-
Livingston, B.D.1
Alexander, J.2
Crimi, C.3
Oseroff, C.4
Celis, E.5
Daly, K.6
Guidotti, L.G.7
Chisari, F.V.8
Fikes, J.9
Chesnut, R.W.10
Sette, A.11
-
26
-
-
0035860626
-
Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines
-
Livingston, B. D., M. Newman, C. Crimi, D. McKinney, R. Chesnut, and A. Sette. 2001. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 19:4652-4660.
-
(2001)
Vaccine
, vol.19
, pp. 4652-4660
-
-
Livingston, B.D.1
Newman, M.2
Crimi, C.3
McKinney, D.4
Chesnut, R.5
Sette, A.6
-
27
-
-
0036604410
-
A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes
-
Livingston, B., C. Crimi, M. Newman, Y. Higashimoto, E. Appella, J. Sidney, and A. Sette. 2002. A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J. Immunol. 168:5499-5506.
-
(2002)
J. Immunol
, vol.168
, pp. 5499-5506
-
-
Livingston, B.1
Crimi, C.2
Newman, M.3
Higashimoto, Y.4
Appella, E.5
Sidney, J.6
Sette, A.7
-
28
-
-
33847701354
-
Chronic hepatitis B
-
Lok, A. S., and B. J. McMahon. 2007. Chronic hepatitis B. Hepatology 45:507-539.
-
(2007)
Hepatology
, vol.45
, pp. 507-539
-
-
Lok, A.S.1
McMahon, B.J.2
-
29
-
-
0034678435
-
+ cells in liver damage and viral control during persistent hepatitis B virus infection
-
+ cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191:1269-1280.
-
(2000)
J. Exp. Med
, vol.191
, pp. 1269-1280
-
-
Maini, M.K.1
Boni, C.2
Lee, C.K.3
Larrubia, J.R.4
Reignat, S.5
Ogg, G.S.6
King, A.S.7
Herberg, J.8
Gilson, R.9
Alisa, A.10
Williams, R.11
Vergani, D.12
Naoumov, N.V.13
Ferrari, C.14
Bertoletti, A.15
-
30
-
-
20744456789
-
Solid phase peptide synthesis I: The synthesis of a tetrapeptide
-
Merrifield, R. B. 1963. Solid phase peptide synthesis I: the synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:2149-2154.
-
(1963)
J. Am. Chem. Soc
, vol.85
, pp. 2149-2154
-
-
Merrifield, R.B.1
-
31
-
-
0037853316
-
New allele frequency database: http://www.allelefrequencies.net
-
Middleton, D., L. Menchaca, H. Rood, and R. Komerofsky. 2003. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 61:403-407.
-
(2003)
Tissue Antigens
, vol.61
, pp. 403-407
-
-
Middleton, D.1
Menchaca, L.2
Rood, H.3
Komerofsky, R.4
-
32
-
-
0027394383
-
HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis
-
Missale, G., A. Redeker, J. Person, P. Fowler, S. Guilhot, H. J. Schlicht, C. Ferrari, and F. V. Chisari. 1993. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177:751-762.
-
(1993)
J. Exp. Med
, vol.177
, pp. 751-762
-
-
Missale, G.1
Redeker, A.2
Person, J.3
Fowler, P.4
Guilhot, S.5
Schlicht, H.J.6
Ferrari, C.7
Chisari, F.V.8
-
33
-
-
6344272747
-
Cellular immune responses to the hepatitis B virus polymerase
-
Mizukoshi, E., J. Sidney, B. Livingston, M. Ghany, J. H. Hoofhagle, A. Sette, and B. Rehermann. 2004. Cellular immune responses to the hepatitis B virus polymerase. J. Immunol. 173:5863-5871.
-
(2004)
J. Immunol
, vol.173
, pp. 5863-5871
-
-
Mizukoshi, E.1
Sidney, J.2
Livingston, B.3
Ghany, M.4
Hoofhagle, J.H.5
Sette, A.6
Rehermann, B.7
-
34
-
-
0342614926
-
Codon usage tabulated from international DNA sequence databases: Status for the year 2000
-
Nakamura, Y., T. Gojobori, and T. Ikemura. 2000. Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res. 28:292.
-
(2000)
Nucleic Acids Res
, vol.28
, pp. 292
-
-
Nakamura, Y.1
Gojobori, T.2
Ikemura, T.3
-
35
-
-
0027297761
-
HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection
-
Nayersina, R., P. Fowler, S. Guilhot, G. Missale, A. Cerny, H. J. Schlicht, A. Vitiello, R. Chesnut, J. L. Person, A. G. Redeker, and F. V. Chisari. 1993. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659-4671.
-
(1993)
J. Immunol
, vol.150
, pp. 4659-4671
-
-
Nayersina, R.1
Fowler, P.2
Guilhot, S.3
Missale, G.4
Cerny, A.5
Schlicht, H.J.6
Vitiello, A.7
Chesnut, R.8
Person, J.L.9
Redeker, A.G.10
Chisari, F.V.11
-
36
-
-
0029994971
-
Viral dynamics in hepatitis B virus infection
-
Nowak, M. A., S. Bonhoeffer, A. M. Hill, R. Boehme, H. C. Thomas, and H. McDade. 1996. Viral dynamics in hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 93:4398-4402.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 4398-4402
-
-
Nowak, M.A.1
Bonhoeffer, S.2
Hill, A.M.3
Boehme, R.4
Thomas, H.C.5
McDade, H.6
-
37
-
-
0018500742
-
Use of a monoclonal antibody (W6/32) in structural studies in HLA-A,B,C, antigens
-
Parham, P., C. J. Barnstable, and W. F. Bodmer. 1979. Use of a monoclonal antibody (W6/32) in structural studies in HLA-A,B,C, antigens. J. Immunol. 123:342-349.
-
(1979)
J. Immunol
, vol.123
, pp. 342-349
-
-
Parham, P.1
Barnstable, C.J.2
Bodmer, W.F.3
-
38
-
-
0034948510
-
Efficacy and limitations of a specific immunotherapy in chronic hepatitis B
-
Pol, S., B. Nalpas, F. Driss, M. L. Michel, P. Tiollais, J. Denis, C. Brechot, et al. 2001. Efficacy and limitations of a specific immunotherapy in chronic hepatitis B. J. Hepatol. 34:917-921.
-
(2001)
J. Hepatol
, vol.34
, pp. 917-921
-
-
Pol, S.1
Nalpas, B.2
Driss, F.3
Michel, M.L.4
Tiollais, P.5
Denis, J.6
Brechot, C.7
-
39
-
-
0028925535
-
The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis
-
Rehermann, B., P. Fowler, J. Sidney, J. Person, A. Redeker, M. Brown, B. Moss, A. Sette, and F. V. Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047-1058.
-
(1995)
J. Exp. Med
, vol.181
, pp. 1047-1058
-
-
Rehermann, B.1
Fowler, P.2
Sidney, J.3
Person, J.4
Redeker, A.5
Brown, M.6
Moss, B.7
Sette, A.8
Chisari, F.V.9
-
40
-
-
0030008076
-
Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection
-
Rehermann, B., D. Lau, J. H. Hoofnagle, and F. V. Chisari. 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Investig. 97:1655-1665.
-
(1996)
J. Clin. Investig
, vol.97
, pp. 1655-1665
-
-
Rehermann, B.1
Lau, D.2
Hoofnagle, J.H.3
Chisari, F.V.4
-
41
-
-
0037029652
-
Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection
-
Reignat, S., G. J. Webster, D. Brown, G. S. Ogg, A. King, S. L. Seneviratne, G. Dusheiko, R. Williams, M. K. Maini, and A. Bertoletti. 2002. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J. Exp. Med. 195:1089-1101.
-
(2002)
J. Exp. Med
, vol.195
, pp. 1089-1101
-
-
Reignat, S.1
Webster, G.J.2
Brown, D.3
Ogg, G.S.4
King, A.5
Seneviratne, S.L.6
Dusheiko, G.7
Williams, R.8
Maini, M.K.9
Bertoletti, A.10
-
42
-
-
0030959049
-
Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B
-
Rossol, S., G. Marinos, P. Carucci, M. V. Singer, R. Williams, and N. V. Naoumov. 1997. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J. Clin. Investig. 99:3025-3033.
-
(1997)
J. Clin. Investig
, vol.99
, pp. 3025-3033
-
-
Rossol, S.1
Marinos, G.2
Carucci, P.3
Singer, M.V.4
Williams, R.5
Naoumov, N.V.6
-
43
-
-
0032992117
-
The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response
-
Schlaak, J. F., G. Tully, H. F. Lohr, G. Gerken, and K. H. Meyer zum Buschenfelde. 1999. The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response. J. Hepatol. 30:353-358.
-
(1999)
J. Hepatol
, vol.30
, pp. 353-358
-
-
Schlaak, J.F.1
Tully, G.2
Lohr, H.F.3
Gerken, G.4
Meyer zum Buschenfelde, K.H.5
-
44
-
-
37349030369
-
A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B: A phase HA clinical trial
-
Schneider, J., W. Halota, D. Delic, Z. Nesic, D. Prokopowicz, R. Flisiak, J. Kuydowicz, M. Jablokowski, J. Cianciara, T. Mach, R. Modrzewska, M. Fabri, D. Tomic, A. Horban, W. Krycka, and M. Cripps. 2006. A novel primeboost therapeutic vaccine induces sustained seroconversion at 52 weeks in patients with HBeAg+ chronic hepatitis B: a phase HA clinical trial. J. Hepatol. 44(Suppl. 2):S277.
-
(2006)
J. Hepatol
, vol.44
, Issue.SUPPL. 2
-
-
Schneider, J.1
Halota, W.2
Delic, D.3
Nesic, Z.4
Prokopowicz, D.5
Flisiak, R.6
Kuydowicz, J.7
Jablokowski, M.8
Cianciara, J.9
Mach, T.10
Modrzewska, R.11
Fabri, M.12
Tomic, D.13
Horban, A.14
Krycka, W.15
Cripps, M.16
-
45
-
-
0028106321
-
Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays
-
Sette, A., J. Sidney, M. F. del Guercio, S. Southwood, J. Ruppert, C. Dahlberg, H. M. Grey, and R. T. Kubo. 1994. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 31:813-822.
-
(1994)
Mol. Immunol
, vol.31
, pp. 813-822
-
-
Sette, A.1
Sidney, J.2
del Guercio, M.F.3
Southwood, S.4
Ruppert, J.5
Dahlberg, C.6
Grey, H.M.7
Kubo, R.T.8
-
46
-
-
0027973079
-
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes
-
Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. Melief, C. Oseroff, L. Yuan, J. Ruppert, J. Sidney, M. F. del Guercio, S. Southwood, R. T. Kubo, R. W. Chesnut, H. M. Grey, and F. V. Chisari. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586-5592.
-
(1994)
J. Immunol
, vol.153
, pp. 5586-5592
-
-
Sette, A.1
Vitiello, A.2
Reherman, B.3
Fowler, P.4
Nayersina, R.5
Kast, W.M.6
Melief, C.J.7
Oseroff, C.8
Yuan, L.9
Ruppert, J.10
Sidney, J.11
del Guercio, M.F.12
Southwood, S.13
Kubo, R.T.14
Chesnut, R.W.15
Grey, H.M.16
Chisari, F.V.17
-
47
-
-
0033388724
-
Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
-
Sette, A., and J. Sidney. 1999. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50:201-212.
-
(1999)
Immunogenetics
, vol.50
, pp. 201-212
-
-
Sette, A.1
Sidney, J.2
-
48
-
-
0035863924
-
Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice
-
Sette, A. D., C. Oseroff, J. Sidney, J. Alexander, R. W. Chesnut, K. Kakimi, L. G. Guidotti, and F. V. Chisari. 2001. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice. J. Immunol. 166:1389-1397.
-
(2001)
J. Immunol
, vol.166
, pp. 1389-1397
-
-
Sette, A.D.1
Oseroff, C.2
Sidney, J.3
Alexander, J.4
Chesnut, R.W.5
Kakimi, K.6
Guidotti, L.G.7
Chisari, F.V.8
-
49
-
-
0024542612
-
Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line
-
Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J. Immunol. 142:3320-3328.
-
(1989)
J. Immunol
, vol.142
, pp. 3320-3328
-
-
Shimizu, Y.1
DeMars, R.2
-
50
-
-
0030587791
-
Specificity and degeneracy in peptide binding to HLA-B7-like class 1 molecules
-
Sidney, J., S. Southwood, M. F. del Guercio, H. M. Grey, R. W. Chesnut, R. T. Kubo, and A. Sette. 1996. Specificity and degeneracy in peptide binding to HLA-B7-like class 1 molecules. J. Immunol. 157:3480-3490.
-
(1996)
J. Immunol
, vol.157
, pp. 3480-3490
-
-
Sidney, J.1
Southwood, S.2
del Guercio, M.F.3
Grey, H.M.4
Chesnut, R.W.5
Kubo, R.T.6
Sette, A.7
-
51
-
-
37349087430
-
-
Sidney, J., S. Southwood, C. Oseroff, M-F. del Guercio, A. Sette, and H. M. Grey. 1998. Measurement of MHC/peptide interactions by gel filtration, p. 18.3.1-18.3.19. In J. E. Coligan et al. (ed.), Current protocols in immunology John Wiley & Sons, New York, NY.
-
Sidney, J., S. Southwood, C. Oseroff, M-F. del Guercio, A. Sette, and H. M. Grey. 1998. Measurement of MHC/peptide interactions by gel filtration, p. 18.3.1-18.3.19. In J. E. Coligan et al. (ed.), Current protocols in immunology John Wiley & Sons, New York, NY.
-
-
-
-
52
-
-
0034953906
-
Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia
-
Sobao, Y., K. Sugi, H. Tomiyama, S. Saito, S. Fujiyama, M. Morimoto, S. Hasuike, H. Tsubouchi, K. Tanaka, and M. Takiguch. 2001. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia. J. Hepatol. 34:922-929.
-
(2001)
J. Hepatol
, vol.34
, pp. 922-929
-
-
Sobao, Y.1
Sugi, K.2
Tomiyama, H.3
Saito, S.4
Fujiyama, S.5
Morimoto, M.6
Hasuike, S.7
Tsubouchi, H.8
Tanaka, K.9
Takiguch, M.10
-
53
-
-
0032055915
-
Several common HLA-DR types share largely overlapping peptide binding repertoires
-
Southwood, S., J. Sidney, A. Kondo, M. F. del Guercio, E. Appella, S. Hoffman, R. T. Kubo, R. W. Chesnut, H. M. Grey, and A. Sette. 1998. Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160:3363-3373.
-
(1998)
J. Immunol
, vol.160
, pp. 3363-3373
-
-
Southwood, S.1
Sidney, J.2
Kondo, A.3
del Guercio, M.F.4
Appella, E.5
Hoffman, S.6
Kubo, R.T.7
Chesnut, R.W.8
Grey, H.M.9
Sette, A.10
-
54
-
-
0002752973
-
Improved media for growing plasmic and cosmid clones
-
Tartof, K. D., and C. A. Hobbs. 1987. Improved media for growing plasmic and cosmid clones. Bethesda Res. Lab. Focus 9:12.
-
(1987)
Bethesda Res. Lab. Focus
, vol.9
, pp. 12
-
-
Tartof, K.D.1
Hobbs, C.A.2
-
55
-
-
0025729554
-
Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex
-
Vitiello, A., D. Marchesini, J. Furze, L. A. Sherman, and R. W. Chesnut. 1991. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173:1007-1015.
-
(1991)
J. Exp. Med
, vol.173
, pp. 1007-1015
-
-
Vitiello, A.1
Marchesini, D.2
Furze, J.3
Sherman, L.A.4
Chesnut, R.W.5
-
56
-
-
10744230389
-
Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1
-
Wilson, C. C., D. McKinney, M. Anders, S. MaWhinney, J. Forster, C. Crimi, S. Southwood, A. Sette, R. Chesnut, M. J. Newman, and B. D. Livingston. 2003. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1. J. Immunol. 171:5611-5623.
-
(2003)
J. Immunol
, vol.171
, pp. 5611-5623
-
-
Wilson, C.C.1
McKinney, D.2
Anders, M.3
MaWhinney, S.4
Forster, J.5
Crimi, C.6
Southwood, S.7
Sette, A.8
Chesnut, R.9
Newman, M.J.10
Livingston, B.D.11
-
57
-
-
0024720605
-
The RAMPS system: Simplified peptide synthesis for life science researchers
-
Wolfe, H. R., and R. R. Wilk. 1989. The RAMPS system: simplified peptide synthesis for life science researchers. Pept. Res. 2:352-356.
-
(1989)
Pept. Res
, vol.2
, pp. 352-356
-
-
Wolfe, H.R.1
Wilk, R.R.2
|